Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Filippo de Marinis, Francesca Porta, Elena Guerini-Rocco, Carmine Valenza, Giuseppe Curigliano, Chiara Catania, Alessandra Rappa, Massimo Barberis, Giuseppe Viale
Publikováno v:
Current Oncology, Vol 28, Iss 292, Pp 3384-3392 (2021)
Current Oncology
Current Oncology
We present a case of a woman with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma who received gefitinib for 2 years and obtained a partial response. The patient then developed liver metastasis and a breast lesion, displaying high
Publikováno v:
Current Oncology
Volume 22
Issue 5
Pages 2635-399
Volume 22
Issue 5
Pages 2635-399
Kaposi sarcoma (ks) is a vascular tumour caused by oncogenic human herpesvirus type 8
it often occurs with hiv-associated immunosuppression. Numerous cellular signalling pathways are involved in the pathogenesis of ks, among which receptor tyros
it often occurs with hiv-associated immunosuppression. Numerous cellular signalling pathways are involved in the pathogenesis of ks, among which receptor tyros
Publikováno v:
Current Oncology
Volume 15
Issue 4
Pages 228-197
Vrije Universiteit Brussel
Volume 15
Issue 4
Pages 228-197
Vrije Universiteit Brussel
Cetuximab, a monoclonal antibody directed against the epidermal growth factor receptor, has activity against colorectal cancer. Treatment is associated with skin toxicity, and the safety of cetuximab in patients with psoriasis is unknown. We report t